A recent House subcommittee hearing centered on concerns that private equity's investment model purportedly focuses on maximizing profit to the detriment of patient welfare. (Photo: Shutterstock.com)
Private equity investment in health care companies has garnered increasingly critical attention from the federal government, including recent scrutiny by Congress: In March 2021, the Oversight Subcommittee of the U.S. House of Representatives' Ways and Means Committee held a hearing on "Examining Private Equity's Expanded Role in the U.S. Health Care System."
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
- Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
- Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
Already have an account? Sign In
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
